You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:

Merck announces significant price cut to its AIDS drugs, Stocrin and Isentress

Author: AIDS Healthcare Foundation, Published on: 1 August 2008

AIDS Healthcare Foundation…commended Merck…over price cuts on two of its key AIDS drugs in Mexico... Merck cut its price of Stocrin…in Mexico by 40%...and on Isentress…by 30%... [According to] Michael Weinstein, AIDS Healthcare Foundation President…“Though there is still much to be done in the fight for affordable lifesaving AIDS drugs in Mexico and throughout the world…we commend Merck today for instituting these double digit price reductions in response to activists’ pleas for lower prices…”


Read the full post here

Related companies: Merck Merck Sharp & Dohme (part of Merck)